Clinical Trial Update: Prognosis Assessment of the Increase of GADD34 Gene Expression for Patient Suffering From Systemic Lupus Erythematosus [NA]

View source ↗

Summary

This completed clinical trial investigates whether increased GADD34 gene expression has prognostic value for patients with systemic lupus erythematosus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Snippet

Sponsor: University Hospital, Grenoble | Conditions: Lupus Erythematosus | NA | Status: COMPLETED